FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Genzyme Thyrogen Recall

Thyrogen (thyrotropin alfa for injection), 0

Genzyme Corporation · Cambridge, MA

Risk level
Class II
Reported by FDA
Mar 9, 2016
Recall ID
D-0730-2016
Check your lot numberHow we source this data

Summary

Genzyme recalled Thyrogen starting Feb 16, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0730-2016 on Mar 9, 2016. Reason: Presence of Particulate Matter: Glass particles found in the product after reconstitution. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Glass particles found in the product after reconstitution.

Product description

Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.

Lot numbers, UPCs & expiration codes

Lot #s: E4029Y03, E4029Y04, E4029Y06, E4029Y07, Exp 12/2017

Where it was sold

Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0730-2016
Classification
Class II
Status
Terminated
Recall initiated
Feb 16, 2016
FDA report date
Mar 9, 2016
Quantity
4669 Cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Genzyme Corporation

Original FDA data

Every field from FDA enforcement report D-0730-2016, exactly as published.

Show all FDA fields
City
Cambridge
State
MA
Status
Terminated
Country
United States
Event ID
73301
Address
500 Kendall Street
Address (line 2)
675 West Kendall/55 Cambridge Parkway
Code information
Lot #s: E4029Y03, E4029Y04, E4029Y06, E4029Y07, Exp 12/2017
Postal code
02142-1108
Report date
Mar 9, 2016
Product type
Drugs
Recall number
D-0730-2016
Classification
Class II
Recalling firm
Genzyme Corporation
Product quantity
4669 Cartons
Termination date
Mar 2, 2017
Reason for recall
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.
Distribution pattern
Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
Recall initiation date
Feb 16, 2016
Initial firm notification
Telephone
Center classification date
Feb 26, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0730-2016, published Mar 9, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls